Is Mangoceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Mangoceuticals Inc (MGRX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Mangoceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mangoceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Mangoceuticals Inc?

Muslim investors may consider investing in Mangoceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Mangoceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Mangoceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Mangoceuticals Inc updated?

The Shariah compliance status of Mangoceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Mangoceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Mangoceuticals Inc?

You can check the latest Shariah compliance status of Mangoceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MGRX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 06, 2026

Report Source: 2025 Annual Report

Mangoceuticals Inc. Stock Analysis MGRX

United States Consumer Discretionary Nano Cap Report: 2025 Annual

Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The company is advancing its proprietary antiviral compound MGX-0024. The firm offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. The company has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.

Key Statistics of Mangoceuticals Inc (MGRX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.39$0.46

Today's Open

$0.39

Volume

823.22K

P/E Ratio (TTM)

52 Week Range

$0.16$2.75

Market Cap

5.43M

Avg. Volume

826.14K

Dividend Yield

Financial Metrics & Statements of Mangoceuticals Inc (MGRX)

FAQ's for Mangoceuticals Inc (MGRX)

According to Musaffa’s Shariah screening methodology, Mangoceuticals Inc (MGRX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.